WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.

Raccontata daelespectador.comkoreatimes.co.krkoreaherald.compharmaceutical-technology.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
pharmaceutical-technology.comStai leggendo14 h fa

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.

originale

Timeline cronologica

  1. lunedì 25 maggio 2026·elespectador.com

    Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas

    Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

  2. martedì 26 maggio 2026·koreatimes.co.kr

    SK Bioscience to license vaccine technology to Colombia - The Korea Times

    SK Bioscience will license its vaccine technology to Colombia’s state-owned pharmaceutical firm VECOL and cooperate in establishing a local manufac...

koreaherald.com
1 g fa

SK Bioscience joins Colombia’s vaccine localization project

SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo

Leggi questa versione → originale
koreatimes.co.kr1 g fa

SK Bioscience to license vaccine technology to Colombia - The Korea Times

SK Bioscience signed a technology licensing agreement with Colombia's VECOL, including 600,000 doses of SKYVaricella ordered for 2026, backed by a $260M national vaccine localization program over 10 years. The deal signals a growing market for WHO-prequalified vaccine manufacturers willing to commit to in-country tech transfer — a model increasingly required for public health procurement across emerging markets.

Leggi questa versione → originale
elespectador.com2 g fa

Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas

Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

Leggi questa versione → originale
  • martedì 26 maggio 2026·koreaherald.com

    SK Bioscience joins Colombia’s vaccine localization project

    SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo

  • mercoledì 27 maggio 2026·pharmaceutical-technology.com

    SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

    SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.